Feeder-Free Isolation of Human Trophoblast Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and culturing human trophoblast stem cells are inefficient and often contaminated with animal-derived components, limiting their scalability and therapeutic applications due to the reliance on feeder cells and immunosurgery for initial derivation.
Innovation Solution
A method for isolating human villous trophoblast stem cells from ectopic pregnant mass-derived trophoblastic villi, involving enzymatic treatment and culture in a feeder-layer-free medium, which expresses specific markers and maintains pluripotency, allowing for differentiation into various cell types and potential therapeutic use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If feeder cells and immunosurgery are used for initial derivation, then human trophoblast stem cells can be obtained, but the preparation is contaminated with animal-derived components and scalability is limited
Solution Approach 1:
The invention extracts and removes the harmful animal-derived components (feeder cells and immunosurgery reagents) from the cell derivation process. By using a feeder-free culture system with defined human-derived components, the method eliminates contamination sources while maintaining cell viability and proliferation capacity, thereby achieving both high purity and scalability
Solution Approach 2:
The invention introduces an intermediary defined culture medium system that mediates between the need for cell support and the requirement for purity. This medium contains specific growth factors and nutrients that replace the function of animal feeder cells, enabling human trophoblast stem cells to proliferate without contamination while maintaining their stem cell properties
2Productivity
If feeder cells are used for culture, then cell proliferation is supported, but contamination with animal-derived components occurs
Solution Approach 1:
The invention changes the chemical and biological parameters of the culture system by replacing undefined animal-derived feeder cell components with a defined medium containing specific growth factors (such as bFGF), nutrients, and supplements at controlled concentrations. This parameter change maintains the proliferative support function while eliminating animal contamination, achieving both high productivity and reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the isolation of pure human villous trophoblast stem cells capable of indefinite proliferation and multilineage differentiation, reducing contamination risks and enabling their use in therapeutic applications such as treating neurodegenerative diseases and cancer.
Implementation Method 1
involving enzymatic treatment and culture in a feeder-layer-free medium
Data Source
AI summary
Disclosed herein are human trophoblast stem (hTS) cells, differentiated cells thereof, derivatives thereof, such as a cellular mass, and uses thereof. The isolation of hTS cells can express FGF4, FGFR-2, Oct4, Thy-1, and stage-specific embryonic antigens distributed in different compartments of the cell. The hTS cells are able to derive into specific cell phenotypes of the three primitive embryonic layers, produce chimeric reactions in mice, and retain a normal karyotype and telomere length. In the hTS cells, Oct4 and FGFR-2 expressions can be knocked down by bFGF. The hTS cells could apply to human cell differentiation and for gene and cell-based therapies.